1.
Peters A. Emerging therapeutic agents in the treatment of relapsed or refractory diffuse large B cell lymphoma. Can Hematol Today [Internet]. 2022 Mar. 1 [cited 2024 Apr. 27];1(1):43–47. Available from: https://canadianhematologytoday.com/article/view/1-1-6-peters